How Much Did Phage Lab Raise?
Funding & Key Investors

Phage Lab has secured $11M in total capital, with its most recent financing round bringing in $11M in a major strategic investment. This significant backing underscores the company's pivotal role in developing advanced bacteriophage treatments aimed at combating bacterial challenges, particularly within the livestock industry.

What is Phage Lab?

Phage Lab
Business ServicesResearch & Development

Phage Lab is a biotechnology firm headquartered in Santiago, Chile, with operations extending to Spain and Brazil. The company specializes in precision bacteriophage therapies designed to mitigate the overuse of antibiotics in livestock breeding. Leveraging a sophisticated platform that integrates deep epidemiological diagnostics with over a decade of collected data, Phage Lab offers effective solutions for bacterial population control. Their core mission is to pioneer personalized bacteriophage treatments to address global bacterial threats, positioning them at the forefront of innovative antimicrobial strategies.

How much funding has Phage Lab raised?

Phage Lab has raised a total of $11M across 1 funding round:

2024

Other Financing Round

$11M

Other Financing Round (2024): $11M with participation from Collaborative Fund and Nazca

Key Investors in Phage Lab

Collaborative Fund

Collaborative Fund is a venture capital firm with over $500 million in assets, known for investing in companies that aim to improve the world. Their portfolio includes notable early-stage investments in various sectors, indicating a focus on innovative and impactful businesses.

Nazca

Nazca appears to be an entity involved in integrated solutions for facility and property management, though its direct relevance to biotechnology is unclear from the provided data. This suggests a potential strategic partnership or a diversified investment approach by the backer.

What's next for Phage Lab?

The substantial enterprise-level funding and recent strategic investment signal a critical growth phase for Phage Lab. This capital infusion is expected to accelerate the company's research and development initiatives, potentially expanding its platform's reach into new markets and applications. The focus on precision treatments and data-driven diagnostics suggests a strategic push towards scaling operations and solidifying its position as a leader in alternative antimicrobial solutions, moving beyond traditional antibiotic reliance.

See full Phage Lab company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Advertising NetworksBusiness ServicesSoftwareCustomer Engagement PlatformsMobile App Development
Business ServicesSoftware TestingSoftwareIndustrial Machinery & EquipmentManufacturingHealthcare Software
Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesCommercial Printing

Frequently Asked Questions Regarding Phage Lab Financial Insights

What are the most recent funding rounds that Phage Lab has completed, and what were the funding rounds?
Phage Lab has recently completed 1 funding rounds: Other Financing Round on Jan 23, 2024.
What is the total amount of funding Phage Lab has raised to date?
Phage Lab has raised a total of $11M in funding to date.
How many funding rounds has Phage Lab completed?
Phage Lab has completed 1 funding rounds.
How much funding did Phage Lab raise in its most recent funding round?
Phage Lab raised $11M in its most recent funding round.
Who are the lead investors in Phage Lab's latest funding round?
The lead investor in Phage Lab's latest funding round was Collaborative Fund. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Phage Lab's history?
The largest funding round in Phage Lab's history was $11M.
See more information about Phage Lab